GANX 8-K 2026-10-01

Gain Therapeutics, Inc. (GANX) 8-K dated 2026-10-01 — accession 0001104659-26-112624. This URL is the filing, not the GANX hub.

Gain Therapeutics, Inc. (GANX) is a biotechnology company listed on US.

Gain Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001104659-26-112624.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GANX revenue for 2023-12-31 was $55.2K. Net income was -$22.3M. GANX currently screens at market cap $53.0M.

Not investment advice. The GANX SEC hub lists recent forms. The stock page is the research view.